HCPCS Code Descriptor:
Injection, brolucizumab-dbll, 1 mg
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
BEOVU is an Opthalmic drug manufactured by Novartis and administered via the Intraocular route of administration. The J Code: J0179 is aligned to the drug BEOVU.
Access Pricing and More By Registering
HCPCS Added Date:
HCPCS Effective Date:
HCPCS Short Description:
Inj, brolucizumab-dbll, 1 mg
Billing and Coding Guide: